Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Emerging concepts in the medical and surgical treatment of obesity.

Aylwin S, Al-Zaman Y.

Front Horm Res. 2008;36:229-59. doi: 10.1159/0000115368. Review.

PMID:
18230906
2.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
3.

[The pharmacological treatment of obesity: past, present and future].

Simonyi G, Pados G, Medvegy M, Bedros JR.

Orv Hetil. 2012 Mar 11;153(10):363-73. doi: 10.1556/OH.2012.29317. Review. Hungarian.

PMID:
22370224
4.

Gut hormones: implications for the treatment of obesity.

Neary MT, Batterham RL.

Pharmacol Ther. 2009 Oct;124(1):44-56. doi: 10.1016/j.pharmthera.2009.06.005. Epub 2009 Jun 26. Review.

PMID:
19560488
5.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

6.

Obesity treatment: novel peripheral targets.

Field BC, Chaudhri OB, Bloom SR.

Br J Clin Pharmacol. 2009 Dec;68(6):830-43. doi: 10.1111/j.1365-2125.2009.03522.x. Review.

7.

Obesity drug therapy.

Baretić M.

Minerva Endocrinol. 2013 Sep;38(3):245-54. Review.

PMID:
24126545
8.

Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?

Miras AD, le Roux CW.

Int J Obes (Lond). 2014 Mar;38(3):325-33. doi: 10.1038/ijo.2013.205. Epub 2013 Nov 11. Review.

9.

Clinical pharmacotherapy for obesity: current drugs and those in advanced development.

Halford JC.

Curr Drug Targets. 2004 Oct;5(7):637-46. Review.

PMID:
15473253
10.

Pharmacotherapy for obesity in menopausal women.

Samat A, Rahim A, Barnett A.

Menopause Int. 2008 Jun;14(2):57-62. doi: 10.1258/mi.2008.008005. Review.

PMID:
18519266
11.

Pharmacotherapy for obesity.

Neff LM, Aronne LJ.

Curr Atheroscler Rep. 2007 Dec;9(6):454-62. Review.

PMID:
18377785
12.

Gastric electrical stimulation: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1.

13.

[Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].

Zieba R.

Postepy Hig Med Dosw (Online). 2007 Oct 19;61:612-26. Review. Polish.

14.

Surgical treatment of obesity.

Bult MJ, van Dalen T, Muller AF.

Eur J Endocrinol. 2008 Feb;158(2):135-45. doi: 10.1530/EJE-07-0145. Review.

15.

Gut peptides and the regulation of appetite.

Huda MS, Wilding JP, Pinkney JH.

Obes Rev. 2006 May;7(2):163-82. Review.

PMID:
16629873
16.

[Association of obesity and depression].

Rihmer Z, Purebl G, Faludi G, Halmy L.

Neuropsychopharmacol Hung. 2008 Oct;10(4):183-9. Review. Hungarian.

17.

New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.

Scheen AJ, Ernest P.

Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45. Review.

18.

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004096. Review.

PMID:
15674929
19.

CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.

Scheen AJ.

J Neuroendocrinol. 2008 May;20 Suppl 1:139-46. doi: 10.1111/j.1365-2826.2008.01681.x. Review.

PMID:
18426513
20.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

Items per page

Supplemental Content

Write to the Help Desk